Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spark Therapeutics
Biotech
SpliceBio sparks eye disease gene therapy collab with Roche unit
SpliceBio is sparking up a new $216 million alliance with Roche’s gene therapy unit to develop a new treatment for an inherited retinal disease.
Annalee Armstrong
Oct 17, 2023 3:00am
Atsena downsizes to funnel money toward new capsid program
Oct 5, 2023 1:47pm
Roche axes hemophilia A gene therapy from pipeline
Jul 27, 2023 6:00am
Pfizer's phase 3 hemophilia gene therapy beats standard of care
Dec 29, 2022 10:36am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
New Spark, in CEO form, for Roche gene therapy—Chutes & Ladders
Feb 25, 2022 9:30am